Multi-Feature Treatment Verification in Particle Therapy


Multi-Feature Treatment Verification in Particle Therapy

Kögler, T.; Alagoz, E.; Beyer, R.; Hammer, S.; Hysing, L. B.; Lutz, B.; Meric, I.; Permatasari, F.; Pettersen, H. E. S.; Römer, K.; Schellhammer, S.; Skjerdal, K.; Turko, J. A. B.; Wagner, A.; Weinberger, D.; Werner, R.-D.; Ytre-Hauge, K.; Pausch, G.

Particle therapy constitutes a promising and rapidly developing method in modern cancer treatment. In order to exploit its full potential, however, it requires detailed dose verification.
Although the applicability of in-beam positron emission tomography and prompt gamma rays has already been demonstrated in patients, range verification is not yet part of the clinical routine in particle therapy. This is due to not only the methodological limitations of previous systems, but also to commercial, clinical and physical boundary conditions.
In pencil beam scanning, the state-of-the-art treatment method in particle therapy, the number of secondary particles (essentially positrons, prompt gamma rays and fast neutrons) available per spot (Δt = 10 ms to 100 ms) is limited. This leads to statistical accuracy limits for verification systems exploiting these secondary particles as range probes. The development of a clinically useable treatment verification system requires gathering as much information about the local dose, as possible.
The instantaneous fluence rate of prompt gamma rays reaching 5×10⁶ cm‾²s‾¹ to 10⁸ cm‾²s‾¹ challenges modern data acquisitions connected to monolithic inorganic scintillators with typical sizes used in present verification systems. In order to reduce the detector load, and also with regard to the ever higher intensities of next generation medical accelerators, future systems have to be more granular.
Multi-Feature Treatment Verification combines and extends established methods (prompt gamma-ray imaging, spectroscopy, timing, etc.) in order to achieve higher reliability and performance. This idea was taken up by the NOVO project and expanded by a multi-particle approach. The NOVO (i.e. N eutron and gamma ray imaging with quasi-monolithic organic detector arrays – a novel, holistic approach to real-time range assessment-based treatment verification in particle therapy) consortium is a large collaboration of medical, nuclear and detector physicists, nuclear engineers, and mathematicians, which aim to develop a holistic realtime treatment verification system in particle therapy.
Elements of a potential multi-feature/multi-particle treatment verification multi-channel system were characterized in a double time-of-flight experiment at the pulsed photo-neutron source nELBE (neutrons @ Electron Linac for beams with high Brilliance and low Emittance). The essential properties (time resolution, light yield, detection efficiency and pulse shape discrimination) of an EJ-276 plastic scintillator were determined. The very first experimental results show that the time resolution (ΔT < 400 ns) of a 20 × 20 × 200 mm³
EJ-276 plastic scintillator with double-sided readout will reach the high demands of such a proposed range verification system. However, the determined quality of the pulse-shape discrimination, the energy resolution and the quite high neutron detection threshold of above 200 keV show that the light yield of this type of scintillator is not high enough to be used in a multi-feature-based treatment verification system. Particle transport calculations with MCNP6 and GEANT4 were performed to confirm the experimental results of a single detector element. Furthermore, they also show a promising measurement accuracy of a multi-channel overall system.

Keywords: particle therapy; treatment verification; in-vivo range assessment; NOVO project

Involved research facilities

Related publications

  • Lecture (Conference)
    The 7th International Conference on Advancements in Nuclear Instrumentation Measurement Methods and their Applications, 21.-25.06.2021, Praha, Česká republika

Permalink: https://www.hzdr.de/publications/Publ-32054